The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 6, 2000, Pages 629-635

  Borowicz, Kinga K ^a   Kleinrok, Zdzisław ^a   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

AMPA kainate receptor; Diazepam; Kindling; LY 300164; Seizure

Indexed keywords

AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DIAZEPAM; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; TALAMPANEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG POTENTIATION; KINDLING; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PASSIVE AVOIDANCE; RAT; SEIZURE;

AMYGDALA; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; DIAZEPAM; DRUG INTERACTIONS; DRUG SYNERGISM; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; KINDLING, NEUROLOGIC; MALE; MICE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; SEIZURES;

EID: 0034044369     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000237     Document Type: Article

References (28)

1. Block F, Schwarz M (1994) The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors. Eur J Pharmacol 256: 149-153
2. Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ (1995) The non-competitive AMPA/KA receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol 281:319-326
3. Borowicz KK, Kleinrok Z, Czuczwar SJ (1999) Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsive activity of clonazepam in three experimental models of epilepsy. Eur J Pharmacol 380:67-72
4. Czuczwar SJ, Kleinrok Z, Turski WA (1996a) Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs. Metab Brain Dis 11:143-152
5. Czuczwar SJ, Kleinrok Z, Turski WA (1996b) Interaction of calcium channel blockers and excitatory amino acid antagonists with conventional antiepileptic drugs. CNS Drug Rev 2:452-467
6. Czuczwar SJ, Świader M, Kuźniar H, Gasior M, Kleinrok Z (1998a) LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs. Eur J Pharmacol 359:103-109
7. Czuczwar SJ, Kamiński R, Gasior M, Kozicka M, Zawadzki A, Kleinrok Z (1998b) LY 300164, a novel non-NMDA receptor antagonist, potentiates the anticonvulsive activity of antiepileptic drugs. In: Korczyn AD (ed) 4th Congress of the European Society for Clinical Neuropharmacology, Eilat, Israel, December 1-4, 1997. Monduzzi Editore, Bologna, pp 35-39
8. DeLorenzo RJ (1988) Mechanisms of action of anticonvulsant drugs. Epilepsia 29 (Suppl 2):S35-S47
9. Dunham NW, Miya TS (1957) A note on a simple approach for determining neurological deficits in rats and mice. J Am Pharmacol Assoc 46:208
10. Dürmüller N, Graggs M, Meldrum BS (1994) The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res 17:167-174
11. Fifkova E, Marsala J (1967) Stereotaxic atlases for the cat, rabbit and rat. In: Bures J, Petran M, Zachar J (eds) Electrophysiological methods in biological research. Academic Press, New York, pp 653-695
12. Goddard G, McIntyre D, Leech C (1986) A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25:295-330
13. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113
14. Löscher W (1998) Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog Neurobiol 54: 721-741
15. Löscher W, Hönack D (1991) Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther 256:432-440
16. Löscher W, Hönack D (1994) Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil. Br J Pharmacol 113:1349-1357
17. Löscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2:145-181
18. Löscher W, Jäckel R, Czuczwar SJ (1986) Is amygdala kindling in rats a model for drug-resistant partial epilepsy? Exp Neurol 93:211-226
19. Macdonald RL, McLean MJ (1986) Anticonvulsant drugs: mechanisms of action. In: Delgado-Escueta AV, Ward AA Jr, Woodbury DM, Porter RJ (eds) Basic Mechanisms of the epilepsies, molecular and cellular approaches. Raven Press, New York, pp 713-736
20. Namba T, Morimoto K, Sato K, Yamata N, Kuroda S (1994) Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy. Brain Res 638:36-44
21. A receptors. FASEB J 4:1469-1480
22. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294
23. Rosenberg HC, Tietz EI, Chiu TH (1989) Tolerance to anticonvulsant effects of diazepam, clonazepam, and clobazam in amygdala-kindled rats. Epilepsia 30:276-285
24. A receptor complex. In: Bowery NG, Nistico G (eds) GABA: basic research and clinical application. Pythagora, Rome, pp 102-134
25. Tarnawa I, Farkas S, Berzsenyi P, Pataki A, Andrasi F (1989) Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466. Eur J Pharmacol 213:151-153
26. Tietz EI, Gomez F, Berman RF (1984) Amygdala kindled seizure stage is related to altered benzodiazepine binding site density. Life Sci 36:183-190
27. Venault P, Chapoutier G, De Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J (1986) Benzodiazepines impair and betacarbolines enhance performance in learning and memory tasks. Nature 321:864-866
28. Żarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ (1993) 2,3-Dihydroxy-6-nitro-7-sulfamoylbenzo-(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice. Neuropharmacology 32:895-900